acquity uplc peptide beh c18 column 300å Buyer Guide,Peptide

In the complex world of peptide analysis, achieving sharp peaks and reliable separations is paramount. The ACQUITY UPLC Peptide BEH C18 Column, 300Å, 1.7 µm from Waters has emerged as a leading solution, engineered specifically to meet the demanding requirements of proteomics and peptide mapping. This article delves into the technical specifications, unique features, and applications of this advanced chromatographic tool, highlighting why it's a preferred choice for researchers and scientists.

At its core, the ACQUITY UPLC Peptide BEH C18 Column, 300Å, 1.7 µm leverages Waters patented BEH Technology C18. This proprietary technology is built upon trifunctionally bonded BEH particles, which are crucial for achieving superior chromatographic performance. The BEH material is known for its exceptional chemical stability, particularly its widest usable pH range, extending from pH 1–12. This broad pH tolerance allows for greater method development flexibility, enabling users to optimize separation conditions for a diverse array of peptides without compromising column integrity. Furthermore, the BEH particle offers superior low pH stability and ultra-low column bleed, contributing to cleaner baselines and more sensitive detection of analytes.

A key characteristic of this column is its 300Å pore size. This larger pore diameter is specifically designed to accommodate larger biomolecules like peptides, ensuring efficient mass transfer and optimal retention. The 1.7 µm particle size, a hallmark of UPLC (Ultra-Performance Liquid Chromatography), provides high surface area and efficient mass transfer, leading to sharper peaks and significantly improved resolution compared to traditional HPLC systems. This combination of a 300Å pore size and 1.7 µm particles makes the ACQUITY UPLC Peptide BEH C18 Column exceptionally well-suited for peptide analysis.

The C18 bonding on the BEH particles provides strong hydrophobic interaction, which is the primary retention mechanism for most peptide separations. This allows for the effective separation of peptides based on their hydrophobicity, a critical factor in peptide mapping and proteomics workflows. The ACQUITY UPLC and ACQUITY PREMIER Peptide BEH C18 Column series, which includes this specific model, is rigorously tested. Each column comes with a Certificate of Analysis and a Performance Test, often including a peptide map, providing verifiable assurance of its quality and performance.

The ACQUITY UPLC Peptide BEH C18 Column, 300Å, 1.7 µm is available in various dimensions to suit different analytical needs. Common configurations include 2.1 mm X 100 mm and 2.1 mm X 150 mm, offering a balance between sample throughput and resolution. For researchers working with smaller sample volumes or requiring higher sensitivity, the ACQUITY UPLC M-Class Peptide BEH C18 Column is also available, featuring smaller internal diameters (e.g., 75 µm X 150 mm or 75 µm X 250 mm) designed for nano- to micro-scale separations, crucial for biomarker discovery and protein research.

When considering the acquisition of these high-performance columns, potential buyers may encounter various offerings, including new, sealed units, or sometimes, Condition: lightly used options. It is always advisable to purchase from reputable vendors to ensure the authenticity and performance of the column. The ACQUITY BEH300 C18 PST (Peptide Separation Technology) columns are also noteworthy, often sold as kits containing multiple columns with different sorbent batches, facilitating method development and validation.

The versatility of the ACQUITY UPLC Peptide BEH C18 Column, 300Å, 1.7 µm extends to its application in various fields. In biopharmaceutical applications, it is instrumental in characterizing therapeutic proteins and peptides. In proteomics, it aids in the identification and quantification of thousands of peptides from complex biological samples. The 300Å pore size is particularly advantageous for separating larger peptides and even intact proteins, making it a comprehensive tool for biological sample analysis.

In summary, the ACQUITY UPLC Peptide BEH C18 Column, 300Å, 1.7 µm represents a significant advancement in peptide separation technology. Its foundation in Waters proprietary BEH Technology C18, combined with a 300Å pore size and 1.7 µm particles, delivers unparalleled resolution, robustness, and versatility. Whether for routine peptide mapping or cutting-edge proteomics research, this column provides the precision and reliability essential for accurate and reproducible results.